Use of a vegetable extract from salvia haenkei as an active agent in the treatment of heart diseases

1. A method of improving, slowing, relieving and/or reducing heart disease in a subject in need thereof, said method comprising:

administering to a subject in need thereof a Salvia haenkei extract as an active agent, wherein said heart disease is at least one of: cardiac fibrosis, arrythmia, long QT syndrome (QTL), heart failure, heart attack and cardiotoxicity, wherein said heart disease is induced by drugs.

2. The method of claim 1 , wherein said heart disease is cardiac fibrosis.

3. The method of claim 1 , wherein said heart disease is cardiotoxicity.

4. The method of claim 1 , wherein said extract is to be administered via oral route.

5. The method of claim 1 , wherein said extract is to be administered in a dose of 1-5000 mg per day.

6. The method of claim 1 , wherein the Salvia haenkei extract is in the form of a pharmaceutical composition further comprising pharmaceutically acceptable vehicles.

7. The method of claim 6 , wherein said pharmaceutical composition is in the form of tablets, capsules, lozenges, orodispersible films, soft gelatin capsules, granulates or powder, orodispersible powder, liquid solutions, dressing, suspensions, or a combination thereof.

8. The method of claim 1 , wherein the Salvia haenkei extract is in the form of a food supplement.

9. The method of claim 6 , wherein the pharmaceutical composition comprises Salvia haenkei extract in a concentration of 0.1-500 mg/ml when in liquid form, or of 0.1-500 mg/mg when in solid form, of the composition.

10. The method of claim 6 , wherein the pharmaceutical composition comprises Salvia haenkei extract in a concentration of 0.1-500 mg/ml when in liquid form, or of 0.1-500 mg/mg when in solid form, of the supplement.

11. The method of claim 1 , wherein the drugs are chemotherapy drugs.